Bfl-1 is a crucial pro-survival nuclear factor-κB target gene in Hodgkin/Reed-Sternberg cells

International Journal of Cancer

Volumn 129, Issue 12, 2011, Pages 2787-2796

  Loughran, Sinéad T ^a   Campion, Eva M ^a   D'Souza, Brendan N ^a   Smith, Sinéad M ^a   Vrzalikova, Katerina ^b   Wen, Kaisheng ^b   Murray, Paul G ^b   Walls, Dermot ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

apoptosis; Bfl 1; Hodgkin's lymphoma

Indexed keywords

BCL2 RELATED PROTEIN A1; DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I; BCL2-RELATED PROTEIN A1; PROTEIN BCL 2;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DNA BINDING; GENE TARGETING; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REED STERNBERG CELL; REGULATORY MECHANISM; TUMOR BIOPSY; DRUG ANTAGONISM; DRUG EFFECT; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; HODGKIN DISEASE; HUMANS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; REED-STERNBERG CELLS;

EID: 84855170500     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25950     Document Type: Article

References (49)

1. Kanzler H, Kuppers R, Hansmann ML, Rajewsky K,. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495-505. (Pubitemid 26354704)
2. Kuppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann M,. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994; 91: 10962-6.
3. Kuppers R,. Molecular biology of Hodgkin's lymphoma. Adv Cancer Res 2002; 84: 277-312. (Pubitemid 34188200)
4. Kuppers R, Rajewsky K,. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol 1998; 16: 471-93. (Pubitemid 28183373)
5. Younes A, Garg A, Aggarwal BB,. Nuclear transcription factor-kappaB in Hodgkin's disease. Leuk Lymphoma 2003; 44: 929-35. (Pubitemid 36416988)
6. Perkins ND,. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007; 8: 49-62. (Pubitemid 46012014)
7. Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dorken B,. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996; 87: 4340-7. (Pubitemid 26155031)
8. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B,. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997; 100: 2961-9. (Pubitemid 28022832)
9. Kuppers R,. Molecular biology of Hodgkin's lymphoma. Hematology Am Soc Hematol Educ Program 2009; 1: 491- 6.
10. Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Ambinder RF,. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol 2005; 23: 7604-13. (Pubitemid 46291824)
11. Herling M, Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Giardini R, Chilosi M, Kittas C, Gianni AM, et al. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: Associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res 2003; 9: 2114-20. (Pubitemid 36687633)
12. Adams JM, Cory S,. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 2007; 19: 488-96. (Pubitemid 47487452)
13. Letai A,. Pharmacological manipulation of Bcl-2 family members to control cell death. J Clin Invest 2005; 115: 2648-55. (Pubitemid 41434388)
14. Willis SN, Adams JM,. Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 2005; 17: 617-25. (Pubitemid 41540411)
15. Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C,. Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 2001; 97: 2798-807.
16. D'souza BN, Edelstein LC, Pegman PM, Smith SM, Loughran ST, Clarke A, Mehl A, Rowe M, Gelinas C, Walls D,. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. J Virol 2004; 78: 1800-16. (Pubitemid 38176712)
17. Grumont RJ, Rourke IJ, Gerondakis S,. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev 1999; 13: 400-11. (Pubitemid 29108756)
18. Wang CY, Guttridge DC, Mayo MW, Baldwin AS Jr., NF-kappaB induces expression of the bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 1999; 19: 5923-9. (Pubitemid 29399297)
19. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C,. The prosurvival bcl-2 homolog bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev 1999; 13: 382-7. (Pubitemid 29108753)
20. Lee HH, Dadgostar H, Cheng Q, Shu J, Cheng G,. NF-kappaB-mediated up-regulation of bcl-x and bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci USA 1999 Aug 3; 96 (16): 9136-41.
21. Feuerhake F, Kutok JL, Monti S, Chen W, LaCasce AS, Cattoretti G, Kurtin P, Pinkus GS, de Leval L, Harris NL, Savage KJ, Neuberg D, et al. NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood 2005; 106: 1392-9. (Pubitemid 41129606)
22. Monti S, Savage KJ, Kutok JL, Feuerhake F, Kurtin P, Mihm M, Wu B, Pasqualucci L, Neuberg D, Aguiar RC, Dal Cin P, Ladd C, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105: 1851-61. (Pubitemid 40731764)
23. Reynolds GM, Billingham LJ, Gray LJ, Flavell JR, Najafipour S, Crocker J, Nelson P, Young LS, Murray PG,. Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease. Br J Haematol 2002; 118: 195-201. (Pubitemid 34779537)
24. Pegman PM, Smith SM, D'souza BN, Loughran ST, Maier S, Kempkes B, Cahill PA, Simmons MJ, Gelinas C, Walls D,. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJkappa- dependent pathway. J Virol 2006; 80: 8133-44. (Pubitemid 44182313)
25. Brien G, Trescol-Biemont MC, Bonnefoy-Berard N,. Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis. Oncogene 2007; 26: 5828-32. (Pubitemid 47312815)
26. Bornkamm GW, Berens C, Kuklik-Roos C, Bechet JM, Laux G, Bachl J, Korndoerfer M, Schlee M, Holzel M, Malamoussi A, Chapman RD, Nimmerjahn F, et al. Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res 2005; 33: e137.
27. D'Sa-Eipper C, Subramanian T, Chinnadurai G,. Bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res 1996; 56: 3879-82. (Pubitemid 26284731)
28. Jung-Ha H, Kim D, Lee SB, Hong SI, Park SY, Huh J, Kim CW, Kim SS, Lee Y, Choi SS, Shin HS,. Expression of bfl-1 in normal and tumor tissues: Bfl-1 overexpression in cancer is attributable to its preferential expression in infiltrating inflammatory cells. Hum Pathol 1998; 29: 723-8. (Pubitemid 28322058)
29. D'Souza B, Rowe M, Walls D,. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line. J Virol 2000; 74: 6652-8. (Pubitemid 30429836)
30. Ko JK, Lee MJ, Cho SH, Cho JA, Lee BY, Koh JS, Lee SS, Shim YH, Kim CW,. Bfl-1S, a novel alternative splice variant of bfl-1, localizes in the nucleus via its C-terminus and prevents cell death. Oncogene 2003; 22: 2457-65. (Pubitemid 36560729)
31. Keller SA, Schattner EJ, Cesarman E,. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 2000; 96: 2537-42.
32. Mathas S, Lietz A, Janz M, Hinz M, Jundt F, Scheidereit C, Bommert K, Dorken B,. Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis. Blood 2003; 102: 1028-34. (Pubitemid 36917800)
33. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U,. Control of I-kappa-B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 1995; 267: 1485-8.
34. Edelstein LC, Lagos L, Simmons M, Tirumalai H, Gelinas C,. NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor bfl-1/A1. Mol Cell Biol 2003; 23: 2749-61. (Pubitemid 36403075)
35. Kim LH, Nadarajah VS, Peh SC, Poppema S,. Expression of bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma. Histopathology 2004; 44: 257-67. (Pubitemid 38406619)
36. Bai M, Papoudou-Bai A, Horianopoulos N, Grepi C, Agnantis NJ, Kanavaros P,. Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas. Hum Pathol 2007; 38: 103-13. (Pubitemid 44880206)
37. Skinnider BF, Mak TW,. The role of cytokines in classical Hodgkin's lymphoma. Blood 2002; 99: 4283-97. (Pubitemid 34627193)
38. Vockerodt M, Belge G, Kube D, Irsch J, Siebert R, Tesch H, Diehl V, Wolf J, Bullerdiek J, Staratschek-Jox A,. An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591. Br J Haematol 2002; 119: 640-6. (Pubitemid 35366202)
39. Kis LL, Nishikawa J, Takahara M, Nagy N, Matskova L, Takada K, Elmberger PG, Ohlsson A, Klein G, Klein E,. In vitro EBV-infected subline of KMH2, derived from Hodgkin's lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2. Int J Cancer 2005; 113: 937-45. (Pubitemid 40096873)
40. Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT,. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 1999; 18: 3063-70. (Pubitemid 29261226)
41. Emmerich F, Theurich S, Hummel M, Haeffker A, Vry MS, Dohner K, Bommert K, Stein H, Dorken B,. Inactivating IkappaBepsilon mutations in Hodgkin/Reed-Sternberg cells. J Pathol 2003; 201: 413-20. (Pubitemid 37408262)
42. Kashkar H, Deggerich A, Seeger JM, Yazdanpanah B, Wiegmann K, Haubert D, Pongratz C, Kronke M,. NF-kappaB-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs. Blood 2007; 109: 3982-8. (Pubitemid 46641751)
43. Thomas RK, Sos ML, Zander T, Mani O, Popov A, Berenbrinker D, Smola-Hess S, Schultze JL, Wolf J,. Inhibition of nuclear translocation of nuclear factor-kappa B despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. Clin Cancer Res 2005; 11: 8186-94. (Pubitemid 41698763)
44. Karsan A, Yee E, Harlan JM,. Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the bcl-2 family member, A1. J Biol Chem 1996; 271: 27201-4. (Pubitemid 26367264)
45. Morales AA, Olsson A, Celsing F, Osterborg A, Jondal M, Osorio LM,. High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia. Int J Cancer 2005; 113: 730-7. (Pubitemid 40101253)
46. Bernal A, Pastore RD, Asgary Z, Keller SA, Cesarman E, Liou HC, Schattner EJ,. Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood 2001; 98: 3050-7.
47. Pham LV, Tamayo AT, Yoshimura LC, Lo P, Ford RJ,. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. J Immunol 2003; 171: 88-95. (Pubitemid 36745276)
48. Panwalkar A, Verstovsek S, Giles F,. Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies. Cancer 2004; 100: 1578-89. (Pubitemid 38456332)
49. Voorhees PM, Dees EC, O'Neil B, Orlowski RZ,. The proteasome as a target for cancer therapy. Clin Cancer Res 2003; 9: 6316-25. (Pubitemid 38031815)